ASTRAZENECA PHARMA INDIA
Back to Balance Sheet
|
ASTRAZENECA PHARMA INDIA Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹121 Cr | ₹98 Cr | ₹138 Cr | ₹132 Cr | ₹123 Cr |
What is the latest Contingent Liabilities ratio of ASTRAZENECA PHARMA INDIA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹121 Cr |
| Mar2025 | ₹98 Cr |
| Mar2024 | ₹138 Cr |
| Mar2023 | ₹132 Cr |
| Mar2022 | ₹123 Cr |
How is Contingent Liabilities of ASTRAZENECA PHARMA INDIA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹121 Cr | 23.19 | |
| Mar2025 | ₹98 Cr | -28.50 | |
| Mar2024 | ₹138 Cr | 4.57 | |
| Mar2023 | ₹132 Cr | 7.23 | |
| Mar2022 | ₹123 Cr | - | |
Compare Contingent Liabilities of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹17,146.6 Cr | -1% | -13.2% | -24.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,236.0 Cr | -1.8% | -3.7% | 17.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,673.0 Cr | 3.4% | 10.1% | 57.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,460.0 Cr | 1.6% | 0.8% | 37.8% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | -0.4% | -5.6% | -11.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,220.3 Cr | -1.1% | -4.9% | -9.9% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | -1% |
-13.2% |
-24.1% |
| SENSEX | -1.6% |
-4.2% |
-7.2% |
You may also like the below Video Courses